SCHEMBL5512331

SCHEMBL5512331

O=COc1cnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4050731 0.69 — —
SCHEMBL5512329 0.68 — —
SCHEMBL1999107 0.64 — —
SCHEMBL28856862 0.64 — —
SCHEMBL4963218 0.64 — —
SCHEMBL28319712 0.62 — —
SCHEMBL27680736 0.61 HRH3 (0.50) —
SCHEMBL28137559 0.61 — —
SCHEMBL3194879 0.60 — —
SCHEMBL28075275 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1016247-B NOVEL COMPOUND OF IMIDAZOLE CARBOXILIC ACID DERIVATIVE JANSSEN PHARMACEUTICA NV (BE) 1992-04-15 — — CN claimed
CN-86104173-A The preparation method of novel 5-imidazolyl carboxylic acid derivative and their use — 1987-01-28 — — CN claimed
EP-2719688-B1 Process for producing tetrazolyloxime derivatives NIPPON SODA CO (JP) 2016-07-20 — — EP disclosed
EP-2719686-B1 Process to halogenate a picoline derivative NIPPON SODA CO (JP) 2015-12-02 — — EP disclosed
EP-2719687-B1 Process to make a bromopicoline derivative NIPPON SODA CO (JP) 2015-09-16 — — EP disclosed
US-9018385-B2 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative NIPPON SODA CO., LTD. (JP) 2015-04-28 — — US disclosed
US-9012653-B2 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative NIPPON SODA CO., LTD. (JP) 2015-04-21 — — US disclosed
US-9000178-B2 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative NIPPON SODA CO., LTD. (JP) 2015-04-07 — — US disclosed
US-8962848-B2 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative NIPPON SODA CO., LTD. (JP) 2015-02-24 — — US disclosed
US-8841458-B2 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative NIPPON SODA CO., LTD. (JP) 2014-09-23 — — US disclosed
US-20140155611-A1 COMPOUND CONTAINING PYRIDINE RING AND METHOD FOR PRODUCING HALOGENATED PICOLINE DERIVATIVE AND TETRAZOLYLOXIME DERIVATIVE NIPPON SODA CO., LTD. (JP) 2014-06-05 — — US disclosed
EP-2546236-A1 COMPOUND CONTAINING PYRIDINE RING AND METHOD FOR PRODUCING HALOGENATED PICOLINE DERIVATIVE AND TETRAZOLYLOXIME DERIVATIVE Nippon Soda Co., Ltd. (JP) 2013-01-16 — — EP disclosed
US-20130012713-A1 COMPOUND CONTAINING PYRIDINE RING AND METHOD FOR PRODUCING HALOGENATED PICOLINE DERIVATIVE AND TETRAZOLYLOXIME DERIVATIVE NIPPON SODA CO., LTD 2013-01-10 — — US disclosed
US-7223755-B2 Hydroxymorpholinone derivative and medicinal use thereof SENJU PHARMACEUTICAL CO., LTD. (JP) 2007-05-29 — — US disclosed
US-20050176704-A1 Hydroxymorpholinone derivative and medicinal use thereof SENJU PHARMACEUTICAL CO., LTD. (JP) 2005-08-11 — — US disclosed
CN-1090275-A The prodrug of imidazole carboxylic acids as angiotensin II receptor antagonists DU PONT (US) 1994-08-03 — — CN disclosed
CN-1016247-B NOVEL COMPOUND OF IMIDAZOLE CARBOXILIC ACID DERIVATIVE JANSSEN PHARMACEUTICA NV (BE) 1992-04-15 — — CN disclosed
CN-86104173-A The preparation method of novel 5-imidazolyl carboxylic acid derivative and their use — 1987-01-28 — — CN disclosed
CN-86104173-A The preparation method of novel 5-imidazolyl carboxylic acid derivative and their use — 1987-01-28 — — CN disclosed
CN-86104173-A The preparation method of novel 5-imidazolyl carboxylic acid derivative and their use — 1987-01-28 — — CN disclosed
Send feedback